Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
38.55
-0.41 (-1.05%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
31
32
Next >
7 Stocks to Buy if Covid-19 Becomes Endemic
December 20, 2021
Watching the developments of the Covid-19 crisis, it could become endemic. Here’s what that means for certain stocks to buy.
Via
InvestorPlace
GlaxoSmithKline: Investing In Vaccines
December 19, 2021
GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture, and marketing of pharmaceutical and consumer healthcare products. Let's take a look...
Via
Talk Markets
Glaxo-Vir Biotech's Antibody Approved In Europe For Early Treatment Of COVID-19
December 17, 2021
The European Commission (EC) has granted marketing authorization to GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR)...
Via
Benzinga
Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain
December 16, 2021
Two tests from independent labs suggest Adagio's antibody could still target omicron.
Via
Investor's Business Daily
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) expect data from late-stage trials of its COVID-19 booster dose in Q1 2022, instead of this year....
Via
Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
Vir Biotechnology Inc (NASDAQ: VIR) announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic...
Via
Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...
Via
Benzinga
Omicron Surge
December 09, 2021
The seemingly good level of joblessness at a mere 184,000 turns out to be less wonderful than it appears, at the lowest since 1969.
Via
Talk Markets
Wednesday Global Investing Report
December 08, 2021
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international...
Via
Talk Markets
Market Briefing For Wednesday, Dec. 8
December 08, 2021
The surge extended and this time brought more small-caps along with what was a broad advance that is partially attributable to 'hopium' regarding reduced fears about COVID-Omicron.
Via
Talk Markets
Cramer Gives His Opinion On GlaxoSmithKline, Asana And More
December 07, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Penn National Gaming, Inc. (NASDAQ:
Via
Benzinga
Investors Do A Little Holiday Value Shopping On Monday
December 07, 2021
The Nasdaq futures were rallying nearly 2% before the open as technology stocks decide to follow the Dow Jones 30. Many stocks rallied on Monday as early data concerning the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...
Via
Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Canada-based Medicago and GlaxoSmithKline plc (NYSE: GSK) have released Phase 3 data from their plant-derived adjuvanted COVID-19 vaccine candidate....
Via
Benzinga
Exposures
COVID-19
Preclinical Data Shows GSK-Vir COVID-19 Drug Works Against All Omicron Mutations
December 07, 2021
GlaxoSmithKline plc (NYSE: GSK) said that its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology Inc (NASDAQ: VIR) is effective against all...
Via
Benzinga
Exposures
COVID-19
Charms Of China
December 03, 2021
Today the global stock market rout was pretty awful.
Via
Talk Markets
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
December 03, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enbridge Inc. (NYSE:
Via
Benzinga
Thursday Markets Overview
December 02, 2021
Today we are seeing an across-the-board rise in stock prices on hopes for lower inflation and Omicron jabbing.
Via
Talk Markets
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).
Via
InvestorPlace
Apple Issues Negative iPhone 13 Forecast as Boeing Gets "Okay" from China
December 02, 2021
Stock index futures are mixed ahead of the open while investors try to digest yesterday’s selloff. Heavy selling into the close is often seen as a bad sign for stocks, so...
Via
Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...
Via
Benzinga
Exposures
COVID-19
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
VBI Vaccines Inc (NASDAQ: VBIV) has presented updated 12-month and 18-month overall survival (OS) data from the Phase 2a study of VBI-1901, the Company's...
Via
Benzinga
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine Doses
December 02, 2021
The British government has agreed on deals to buy 114 million more Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna Inc (...
Via
Benzinga
Exposures
COVID-19
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced an update to bioRxiv, a preprint server, with preclinical data for...
Via
Benzinga
Exposures
COVID-19
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
Sanofi SA (NASDAQ: SNY) has agreed to buy Austrian group Origimm Biotechnology, a move that will add a potential first-in-class vaccine candidate to treat acne...
Via
Benzinga
Why Did HC Wainwright Beef Up Vir Biotech's Target Price?
November 30, 2021
H.C. Wainwright has raised the Vir Biotechnology Inc (NASDAQ:
Via
Benzinga
Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat
November 30, 2021
Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant.
Via
Investor's Business Daily
Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb
November 30, 2021
They're very similar companies on the surface, but one is planning for a big disruption.
Via
The Motley Fool
VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.
November 30, 2021
Vir Biotechnology has a Covid-19 treatment that its CEO says will do well against new variants. Amid uncertainty, VIR stock is climbing.
Via
InvestorPlace
Exposures
COVID-19
3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries
November 29, 2021
The news of a new variant of the coronavirus Friday sent financial markets into a tailspin. The adversity could present an opportunity for a h...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.